{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:57:49Z","timestamp":1789516669946,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ackdjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1053\/j.ackd.2019.11.003","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T03:08:13Z","timestamp":1592190493000},"page":"128-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Peri- and Post-operative Evaluation and Management of Atypical Hemolytic Uremic Syndrome (aHUS) in Kidney Transplantation"],"prefix":"10.1053","volume":"27","author":[{"given":"Anuja","family":"Java","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.ackd.2019.11.003_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201ckidney disease: improving Global outcomes\u201d (KDIGO) Controversies conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ackd.2019.11.003_bib2","doi-asserted-by":"crossref","first-page":"E130","DOI":"10.1111\/petr.12537","article-title":"Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1\/CFHR3 gene mutation-associated HUS","volume":"19","author":"Grenda","year":"2015","journal-title":"Pediatr Transpl"},{"key":"10.1053\/j.ackd.2019.11.003_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-med-072211-110606","article-title":"Defective complement inhibitory function predisposes to renal disease","volume":"64","author":"Java","year":"2013","journal-title":"Annu Rev Med"},{"issue":"Jan 24","key":"10.1053\/j.ackd.2019.11.003_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-pathol-012615-044145","article-title":"Complement dysregulation and disease: insights from contemporary genetics","volume":"12","author":"Liszewski","year":"2017","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"10.1053\/j.ackd.2019.11.003_bib5","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0034-1375296","article-title":"Genetics of atypical hemolytic uremic syndrome (aHUS)","volume":"40","author":"Rodriguez de Cordoba","year":"2014","journal-title":"Semin Thromb Hemost"},{"issue":"12","key":"10.1053\/j.ackd.2019.11.003_bib6","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome","volume":"21","author":"Dragon-Durey","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2019.11.003_bib7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/ajt.12077","article-title":"Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome","volume":"13","author":"Le Quintrec","year":"2013","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1053\/j.ackd.2019.11.003_bib8","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2019.11.003_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2215\/CJN.00050505","article-title":"Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background","volume":"1","author":"Bresin","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2019.11.003_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5527\/wjn.v2.i3.56","article-title":"Update on hemolytic uremic syndrome: diagnostic and therapeutic recommendations","volume":"2","author":"Salvadori","year":"2013","journal-title":"World J Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2019.11.003_bib11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"issue":"17","key":"10.1053\/j.ackd.2019.11.003_bib12","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1053\/j.ackd.2019.11.003_bib13","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.ackd.2019.11.003_bib14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/MNH.0b013e328365b3fe","article-title":"Managing and preventing atypical hemolytic uremic syndrome recurrence after kidney transplantation","volume":"22","author":"Noris","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"10.1053\/j.ackd.2019.11.003_bib15","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2019.11.003_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2215\/CJN.03270906","article-title":"Screening for complement system abnormalities in patients with atypical hemolytic\u00a0uremic syndrome","volume":"2","author":"Kavanagh","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2019.11.003_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"1","key":"10.1053\/j.ackd.2019.11.003_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ki.2011.330","article-title":"Interpretation of genetic variants of uncertain significance in atypical hemolytic uremic syndrome","volume":"81","author":"Kavanagh","year":"2012","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ackd.2019.11.003_bib19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ekir.2019.04.003","article-title":"A multimodality approach to assessing factor I genetic variants in atypical hemolytic uremic syndrome","volume":"4","author":"Java","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1053\/j.ackd.2019.11.003_bib20","first-page":"1","article-title":"The UNOS scientific renal transplant Registry","author":"Cecka","year":"1999","journal-title":"Clin Transpl"},{"issue":"9","key":"10.1053\/j.ackd.2019.11.003_bib21","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/ajt.14262","article-title":"Complement alternative pathway deficiency in recipients protects kidney allograft from ischemia\/reperfusion injury and alloreactive T cell response","volume":"17","author":"Casiraghi","year":"2017","journal-title":"Am J Transpl"},{"issue":"9","key":"10.1053\/j.ackd.2019.11.003_bib22","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1111\/ajt.13797","article-title":"Targeting complement pathways during cold ischemia and reperfusion prevents delayed graft function","volume":"16","author":"Yu","year":"2016","journal-title":"Am J Transpl"},{"issue":"6","key":"10.1053\/j.ackd.2019.11.003_bib23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.imbio.2015.05.002","article-title":"Patient stratification and therapy in atypical haemolytic uraemic syndrome (aHUS)","volume":"221","author":"Wong","year":"2016","journal-title":"Immunobiology"},{"issue":"27","key":"10.1053\/j.ackd.2019.11.003_bib24","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm6627e1","article-title":"High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine","volume":"66","author":"McNamara","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1053\/j.ackd.2019.11.003_bib25","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/j.ajkd.2017.06.024","article-title":"Living donor kidney transplantation in atypical hemolytic uremic syndrome: a case series","volume":"70","author":"Duineveld","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ackd.2019.11.003_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-6143.2009.02870.x","article-title":"Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T","volume":"10","author":"Waters","year":"2010","journal-title":"Am J Transpl"},{"issue":"11","key":"10.1053\/j.ackd.2019.11.003_bib27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"10.1053\/j.ackd.2019.11.003_bib28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/TP.0000000000000200","article-title":"Atypical hemolytic uremic syndrome recurrence after kidney transplantation","volume":"98","author":"Matar","year":"2014","journal-title":"Transplantation"},{"key":"10.1053\/j.ackd.2019.11.003_bib29","article-title":"Successful prophylactic use of eculizumab in aHUS kidney transplant patients: a report of 9 cases","volume":"16","author":"Kumar","year":"2016","journal-title":"Am J Transpl"},{"issue":"12","key":"10.1053\/j.ackd.2019.11.003_bib30","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1097\/TP.0000000000001909","article-title":"Midterm outcomes of 12 renal transplant recipients treated with eculizumab to prevent atypical hemolytic syndrome recurrence","volume":"101","author":"Levi","year":"2017","journal-title":"Transplantation"},{"issue":"3","key":"10.1053\/j.ackd.2019.11.003_bib31","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ekir.2018.11.010","article-title":"Eculizumab use for kidney transplantation in patients with a diagnosis of atypical hemolytic uremic syndrome","volume":"4","author":"Siedlecki","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1053\/j.ackd.2019.11.003_bib32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"9318","key":"10.1053\/j.ackd.2019.11.003_bib33","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0140-6736(02)08560-4","article-title":"Combined kidney and liver transplantation for familial haemolytic uraemic syndrome","volume":"359","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.ackd.2019.11.003_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrneph.2010.155","article-title":"New insights into postrenal transplant hemolytic uremic syndrome","volume":"7","author":"Zuber","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"10.1053\/j.ackd.2019.11.003_bib35","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1600-6143.2007.01888.x","article-title":"Recurrence of HUS due to CD46\/MCP mutation after renal transplantation: a role for endothelial microchimerism","volume":"7","author":"Fremeaux-Bacchi","year":"2007","journal-title":"Am J Transpl"},{"issue":"4","key":"10.1053\/j.ackd.2019.11.003_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.trre.2013.07.003","article-title":"Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation","volume":"27","author":"Zuber","year":"2013","journal-title":"Transpl Rev (Orlando)"},{"key":"10.1053\/j.ackd.2019.11.003_bib37","first-page":"52","article-title":"Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature","volume":"1","author":"Alasfar","year":"2014","journal-title":"Front Med (Lausanne)"},{"issue":"Suppl 1","key":"10.1053\/j.ackd.2019.11.003_bib38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/nep.12195","article-title":"Atypical HUS associated with severe, unexpected antibody-mediated rejection post kidney transplant","volume":"19","author":"Stevenson","year":"2014","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"10.1053\/j.ackd.2019.11.003_bib39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2215\/CJN.05870710","article-title":"Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies","volume":"6","author":"Meehan","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ackd.2019.11.003_bib40","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/tri.12582","article-title":"Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature","volume":"28","author":"Java","year":"2015","journal-title":"Transpl Int"},{"issue":"2","key":"10.1053\/j.ackd.2019.11.003_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5144\/1658-3876.2011.51","article-title":"Viral-associated thrombotic microangiopathies","volume":"4","author":"Lopes da Silva","year":"2011","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"11","key":"10.1053\/j.ackd.2019.11.003_bib42","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1681\/ASN.2012111064","article-title":"Cyclosporine induces endothelial cell release of complement-activating microparticles","volume":"24","author":"Renner","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2019.11.003_bib43","unstructured":"Soliris (eculizumab). Highlights of Prescribing Information. https:\/\/alexion.com\/Documents\/Soliris_USPI.pdf. Updated June 2019. Accessed May 22, 2020."},{"issue":"1","key":"10.1053\/j.ackd.2019.11.003_bib44","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.transproceed.2016.11.008","article-title":"Eculizumab and belatacept for de novo atypical hemolytic uremic syndrome associated with CFHR3-CFHR1 deletion in a kidney transplant recipient: a case report","volume":"49","author":"Dedhia","year":"2017","journal-title":"Transpl Proc"},{"issue":"1","key":"10.1053\/j.ackd.2019.11.003_bib45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trre.2017.10.001","article-title":"De novo thrombotic microangiopathy after kidney transplantation","volume":"32","author":"Garg","year":"2018","journal-title":"Transpl Rev (Orlando)"},{"issue":"8","key":"10.1053\/j.ackd.2019.11.003_bib46","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/j.1600-6143.2008.02297.x","article-title":"Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation","volume":"8","author":"Le Quintrec","year":"2008","journal-title":"Am J Transpl"},{"issue":"6","key":"10.1053\/j.ackd.2019.11.003_bib47","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/j.1600-6143.2012.03991.x","article-title":"Postpartum aHUS secondary to a genetic abnormality in factor H acquired through liver transplantation","volume":"12","author":"Brown","year":"2012","journal-title":"Am J Transpl"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559519302125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559519302125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:01:41Z","timestamp":1761548501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559519302125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1548559519302125"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2019.11.003","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peri- and Post-operative Evaluation and Management of Atypical Hemolytic Uremic Syndrome (aHUS) in Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2019.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}